Table 6.

Occurrence of adverse events (AEs) in influenza vaccinated oncohematological children.

Adverse events	After 1st dose (n = 91)		After 2nd dose (n = 41)
	Off therapy <6 months (n = 46)	Off therapy 6–24 months (n = 45)	Off therapy <6 months (n = 21)	Off therapy 6–24 months (n = 20)
Systemic events
Fever ≥38 °C rectal	3 (6.5)	4 (8.9)	2 (9.5)	1 (5.0)
Irritability	4 (8.7)	5 (11.1)	2 (9.5)	2 (10.0)
Decreased appetite	3 (6.5)	3 (6.7)	1 (4.8)	1 (5.0)
Rhinitis	2 (4.3)	2 (4.4)	1 (4.8)	1 (5.0)
Cough	3 (6.5)	4 (8.9)	2 (9.5)	2 (10.0)
Vomiting	1 (2.2)	1 (2.2)	1 (4.8)	0 (0.0)
Local events
Redness	2 (4.3)	1 (2.2)	1 (4.8)	1 (5.0)
Swelling/in duration	1 (2.2)	2 (4.4)	0 (0.0)	0 (0.0)
Total with at least one AE	9 (19.6)	10 (22.2)	5 (19.0)	4 (20.0)

Percentages in parentheses. No other AEs were reported.